Vor Bio to Participate in Upcoming Investor Conferences
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, has announced its participation in three upcoming investor conferences in New York, NY. The events include:
1. Morgan Stanley 22nd Annual Global Healthcare Conference - 1x1 Investor Meetings on Friday, September 6, 2024
2. Baird 2024 Global Healthcare Conference - Fireside Chat on Wednesday, September 11, 2024, at 7:55am ET
3. Chardan's 8th Annual Genetic Medicines Conference - Fireside Chat on Monday, September 30, 2024, at 4:30pm ET
These conferences provide Vor Bio with opportunities to engage with investors and showcase their latest developments in cell and genome engineering.
Vor Bio (Nasdaq: VOR), un'azienda in fase clinica specializzata in ingegneria cellulare e genica, ha annunciato la sua partecipazione a tre prossimi convegni per investitori a New York, NY. Gli eventi includono:
1. 22a Conferenza Annuale Globale sulla Salute di Morgan Stanley - Incontri 1x1 con gli investitori, venerdì 6 settembre 2024
2. Conferenza Globale sulla Salute 2024 di Baird - Conversazione informale mercoledì 11 settembre 2024, alle 7:55 ET
3. 8a Conferenza Annuale sui Farmaci Genetici di Chardan - Conversazione informale lunedì 30 settembre 2024, alle 16:30 ET
Questi convegni offrono a Vor Bio l'opportunità di interagire con gli investitori e presentare i loro ultimi sviluppi nell'ingegneria cellulare e genica.
Vor Bio (Nasdaq: VOR), una empresa en etapa clínica dedicada a la ingeniería celular y genómica, ha anunciado su participación en tres próximas conferencias para inversores en New York, NY. Los eventos incluyen:
1. 22ª Conferencia Anual Global de Salud de Morgan Stanley - Reuniones individuales con inversores el viernes 6 de septiembre de 2024
2. Conferencia Global de Salud 2024 de Baird - Charla informal el miércoles 11 de septiembre de 2024, a las 7:55 a. m. ET
3. 8ª Conferencia Anual de Medicamentos Genéticos de Chardan - Charla informal el lunes 30 de septiembre de 2024, a las 4:30 p. m. ET
Estas conferencias brindan a Vor Bio oportunidades para relacionarse con inversores y mostrar sus últimos desarrollos en ingeniería celular y genómica.
Vor Bio (Nasdaq: VOR), 임상 단계의 세포 및 게놈 공학 회사가 뉴욕, NY에서 열리는 3개의 투자자 회의에 참여한다고 발표했습니다. 행사 일정은 다음과 같습니다:
1. 모건 스탠리 제22회 글로벌 헬스케어 컨퍼런스 - 투자자 1:1 미팅: 2024년 9월 6일 금요일
2. 베어드 2024 글로벌 헬스케어 컨퍼런스 - 파이어사이드 챗: 2024년 9월 11일 수요일, 오전 7시 55분 ET
3. 차단 8회 유전자 치료제 컨퍼런스 - 파이어사이드 챗: 2024년 9월 30일 월요일, 오후 4시 30분 ET
이 컨퍼런스들은 Vor Bio가 투자자들과 소통하고 세포 및 게놈 공학의 최신 개발을 선보일 수 있는 기회를 제공합니다.
Vor Bio (Nasdaq: VOR), une entreprise en phase clinique spécialisée dans l'ingénierie cellulaire et génomique, a annoncé sa participation à trois prochaines conférences pour investisseurs à New York, NY. Les événements comprennent :
1. 22e Conférence Annuelle Mondiale sur la Santé de Morgan Stanley - Réunions individuelles avec les investisseurs le vendredi 6 septembre 2024
2. Conférence Mondiale sur la Santé 2024 de Baird - Discussion informelle le mercredi 11 septembre 2024, à 7h55 ET
3. 8e Conférence Annuelle sur les Médicaments Génétiques de Chardan - Discussion informelle le lundi 30 septembre 2024, à 16h30 ET
Ces conférences offrent à Vor Bio l'opportunité d'interagir avec les investisseurs et de présenter ses derniers développements en ingénierie cellulaire et génomique.
Vor Bio (Nasdaq: VOR), ein im klinischen Stadium tätiges Unternehmen für Zell- und Genom-Engineering, hat seine Teilnahme an drei bevorstehenden Investorenkonferenzen in New York, NY angekündigt. Die Veranstaltungen umfassen:
1. 22. Jahrestagung für globale Gesundheitsversorgung von Morgan Stanley - 1x1 Investorenmeetings am Freitag, den 6. September 2024
2. Baird 2024 globale Gesundheitskonferenz - Fireside Chat am Mittwoch, den 11. September 2024, um 7:55 Uhr ET
3. 8. Jahrestagung für genetische Medikamente von Chardan - Fireside Chat am Montag, den 30. September 2024, um 16:30 Uhr ET
Diese Konferenzen bieten Vor Bio die Möglichkeit, mit Investoren in Kontakt zu treten und die neuesten Entwicklungen im Bereich Zell- und Genom-Engineering zu präsentieren.
- None.
- None.
CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:
Morgan Stanley 22nd Annual Global Healthcare Conference
1x1 Investor Meetings: Friday, September 6, 2024
Location: New York, NY
Baird 2024 Global Healthcare Conference
Fireside Chat: Wednesday, September 11, 2024, at 7:55am ET
Location: New York, NY
Chardan’s 8th Annual Genetic Medicines Conference
Fireside Chat: Monday, September 30, 2024, at 4:30pm ET
Location: New York, NY
About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com
FAQ
What investor conferences will Vor Bio (VOR) attend in September 2024?
When and where is Vor Bio's (VOR) fireside chat at the Baird 2024 Global Healthcare Conference?
What type of company is Vor Bio (VOR)?
Where will the investor conferences Vor Bio (VOR) is attending be held?
What is the date and time of Vor Bio's (VOR) presentation at Chardan's 8th Annual Genetic Medicines Conference?
